Alexandra Kropotova
Directeur Technique/Scientifique/R&D chez SAB BIOTHERAPEUTICS, INC.
Fortune : 882 $ au 30/06/2024
Profil
Alexandra Kropotova is an Independent Director at iBio, Inc. since 2020.
She is also the Chief Medical Officer & Executive Vice President at SAB Biotherapeutics, Inc. since 2022.
Previously, she worked as the Director & Head-Global Clinical Respiratory at Pfizer Inc. from 2002 to 2007.
From 2007 to 2016, she served as the Vice President-Strategy & Head-Strategic Planning at Sanofi SA. Dr. Kropotova then joined Teva Pharmaceuticals, Inc. as the VP-Global Specialty Research & Development from 2016 to 2022.
She holds an MBA from Ohio University Graduate College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IBIO, INC.
0,00% | 25/10/2023 | 418 ( 0,00% ) | 882 $ | 30/06/2024 |
| 13/05/2024 | 0 ( -.--% ) | - $ | 30/06/2024 |
Postes actifs de Alexandra Kropotova
| Sociétés | Poste | Début |
|---|---|---|
| IBIO, INC. | Directeur/Membre du Conseil | 14/10/2020 |
| SAB BIOTHERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 06/06/2022 |
Anciens postes connus de Alexandra Kropotova
| Sociétés | Poste | Fin |
|---|---|---|
Teva Pharmaceuticals, Inc.
 Teva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals, Inc. is a leading pharmaceutical company that has been developing and producing medicines for over a century. Teva Pharmaceuticals is based in Parsippany, NJ. The company is a leader in generic and innovative medicines, with a portfolio of over 3,500 products in nearly every therapeutic area. Teva serves around 200 million people worldwide, and has one of the largest and most complex supply chains in the pharmaceutical industry. The company has a significant presence in both generics and innovative medicines research and operations, supporting its growing portfolio of innovative medicines and biopharmaceutical products. | Corporate Officer/Principal | 01/06/2022 |
| Sanofi SA | Corporate Officer/Principal | 01/01/2016 |
| PFIZER, INC. | Directeur/Membre du Conseil | 01/01/2007 |
Formation de Alexandra Kropotova
| Ohio University Graduate College | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| IBIO, INC. | Health Technology |
| SAB BIOTHERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
| Sanofi SA | Health Technology |
Teva Pharmaceuticals, Inc.
Teva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals, Inc. is a leading pharmaceutical company that has been developing and producing medicines for over a century. Teva Pharmaceuticals is based in Parsippany, NJ. The company is a leader in generic and innovative medicines, with a portfolio of over 3,500 products in nearly every therapeutic area. Teva serves around 200 million people worldwide, and has one of the largest and most complex supply chains in the pharmaceutical industry. The company has a significant presence in both generics and innovative medicines research and operations, supporting its growing portfolio of innovative medicines and biopharmaceutical products. | Health Technology |
